Meet the ETF That Beat the S&P 500 for Over 20 Years -- and History Suggests It's Ready to Pop Again

The article attributes recent S&P 500 weakness to volatility and drawdowns in mega-cap tech, noting the “Magnificent Seven” account for about 1/3 of the index’s value and have been hit as investors grow cautious about AI spending. It highlights that the Roundhill Magnificent Seven ETF has fallen more than 13% in the past month, while the rest of the S&P 500 is up over 2.5%—yet the index still dips due to heavy tech weight. It argues the Invesco S&P 500 Equal Weight ETF (RSP), which gives each S&P 500 stock roughly equal weight (e.g., Nvidia ~0.2% vs ~8% in the cap-weighted index), could better damp concentration risk if tech remains under pressure.

Analysis

The market is signaling a rotation from “index ownership” to “earnings ownership.” That matters because cap-weighted exposure is still an implicit levered bet on NVDA/MSFT/AAPL/AMZN/META/GOOGL/TSLA, so any further digestion of AI capex expectations forces passive flows to work against the largest names while mechanically supporting broader-breadth sectors. The second-order winner is not just RSP, but also under-owned cyclicals and financials inside equal-weight exposures that benefit from a lower concentration discount.

Near term, this is mostly a flow trade, not a fundamental regime change: if megacap momentum stabilizes, the relative bid for equal-weight can fade quickly. The important 1-3 month catalyst path is earnings guidance, especially whether cloud/AI spend is being deferred rather than destroyed; if spend merely rotates among vendors, NVDA and MSFT can reclaim leadership and pull the cap-weighted index back up. The falsifier for an equal-weight outperformance thesis is a renewed breadth-narrowing rally led by the same seven names on improving estimates and falling real rates.

Contrarian view: consensus is treating concentration as a risk, but concentration also concentrates earnings growth and buyback capacity. If macro remains soft and long-duration growth reasserts, RSP can look like a “safer” trade that quietly underperforms because it dilutes the only names still compounding above nominal GDP. The overdone/underdone question is timing: the rotation may be real, but the market may be too early in extrapolating it into a durable multi-quarter factor regime.

Key Decisions for Investors

• Long RSP / short QQQ for 1-3 months: express breadth rotation while reducing single-name AI factor risk; stop if QQQ reclaims leadership on improving mega-cap earnings revisions.
• If you want cleaner factor exposure, buy XLF or XLI on weakness versus short XLK: equal-weight strength should mechanically favor broader economic sectors over long-duration tech, but only if rates do not fall sharply.
• Avoid chasing NVDA/META/MSFT on dips until the next earnings/capex checkpoint; the tape is still vulnerable to multiple compression if AI spend is framed as slower ROI, not just higher ROI later.
• Watch for a reversal signal: if the Magnificent Seven outperform the equal-weight basket by ~3-5% over a 2-4 week window on stable yields, cover rotation shorts and re-evaluate the breadth trade.